You are here: Industry Insights > Market News > China, U.S. to send COVID-19 vaccine doses to El Salvador

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

3-Bromo-4-fluorobenzaldehyde

5-Methyl-1,3,4-oxadiazol2(3H)-one

4-Amino-6-methyl-3 oxo2,3, 4,5-tetrahydro 1.2.4-triazine hydrochloride

4-Acetylamino-6-methyl -3-oxo-2,3,4,5-tetrahydro-1,2,4-triazine

3-Pyridinecarboxaldehyde

Ethyl 3 Fluorobenzoate

China, U.S. to send COVID-19 vaccine doses to El Salvador

firstwordpharmaJuly 05, 2021

Tag: Moderna , Vaccine , COVID-19

Favorites

China will send 1.5 million Sinovac COVID-19 vaccines to El Salvador, the Chinese Embassy there announced on Friday, as reported by the National Post.

China, U.S. to send COVID-19 vaccine doses to El Salvador

The announcement came after the White House said the US would send 1.5 million Moderna vaccines to the Central American country.

China said it would send the vaccines in the next few days, while White House press secretary Jen Psaki said the US would send the Moderna doses on Sunday.

Previous:Bharat Biotech Concludes Final Analysis for COVAXIN Efficacy from Phase 3 Clinical Trials

Next:SAHPRA Authorises the CoronaVac Vaccine with Conditions

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

PharmaSourcesNovember 22, 2024

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, today opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts.

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Biotech NewswireNovember 20, 2024

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

PR NEWSWIRENovember 20, 2024

China, U.S. to send COVID-19 vaccine doses to El Salvador | Pharmasources.com

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

Discover how AI in pharmacovigilance improves drug safety by predicting risks, identifying harmful interactions, and enhancing patient outcomes.

You may like
More>>

flu vaccine for 2023-2024 northern hemisphere influenza season

Influenza Vaccine 2022

Hualan's Group ACYW135 Meningococcal Polysaccharide Vaccine

Influenza A (H1N1) Vaccine, (Split, Inactivated)by Hualan biological

Poliomyelitis Vaccine Type I Type III in Dragee Candy (Human Diploid Cell), Live

hualan bio Group ACYW135 Meningococcal Polysaccharide Vaccine according to WHO recommended standard

Influenza Vaccine (Split virion)

Hualan H7N9 Inactivated Influenza Vaccine by Hualan Bio

Poultry Vaccine Series

Hualan Biological Flu Vaccine

China, U.S. to send COVID-19 vaccine doses to El Salvador

Related News

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

You may likeMore>>

You may like
More>>